title: Ranitidine reduces aluminium toxicity in patients with renal failure.
authors.affiliation: Renal Units, Stobhill General Hospital, Glasgow, UK.
authors.forename: K
authors.initials: K
authors.lastname: Czapla
authors.forename: R S
authors.initials: RS
authors.lastname: Rodger
authors.forename: D J
authors.initials: DJ
authors.lastname: Halls
authors.forename: G S
authors.initials: GS
authors.lastname: Muralikrishna
authors.forename: A I
authors.initials: AI
authors.lastname: Macdougall
authors.forename: G S
authors.initials: GS
authors.lastname: Fell
mesh_terms: D000328:Adult; D000368:Aged; D000535:Aluminum / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007408:Intestinal Absorption / Q000187:drug effects; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000097:blood; D011899:Ranitidine / Q000627:therapeutic use*
chemical_list: D010710:Phosphates; D011899:Ranitidine; D000535:Aluminum